Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
Treatment of Acute Disseminated Encephalomyelitis.
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.
Setting new standards in multiple sclerosis care and research.
Immunomodulatory properties of farnesoids: The new steroids?
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
Postpartum complicated by transverse myelitis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
Combinatorial roles for histamine H(1) -H(2) and H(3) -H(4) receptors in autoimmune inflammatory disease of the central nervous system.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Flash Pulmonary Edema in Multiple Sclerosis.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors.
Treatment of primary progressive multiple sclerosis.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
The pathology of multiple sclerosis.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.

Pages